MedPath

Comparison the use of dyrogesterone and steroid in IVF Cycles.

Phase 3
Recruiting
Conditions
Female infertility.
Female infertility
Registration Number
IRCT20181031041519N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
200
Inclusion Criteria

Infertile patients candidates for IVF
AMH greater than 1 ng / ml
First or second IVF cycle
The presence of both ovaries
Age less than 40 years

Exclusion Criteria

Smoking
Presence of uterine anomalies
Adrenal insufficiency or uncontrolled thyroid
Endometriosis grade 3 or More
Couples chromosomal disorder
Underlying disorder that can lead to ovulatory dysfunction
Repeated failure of IVF

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of mature oocyte. Timepoint: Two weeks after treatment. Method of measurement: Vaginal sonography.
Secondary Outcome Measures
NameTimeMethod
H surge. Timepoint: Two weeks after treatment. Method of measurement: Blood test.
© Copyright 2025. All Rights Reserved by MedPath